SCHEMBL39002

SCHEMBL39002

CCN1CCCN2CCN(CC)CCCN(CC1)CC2

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
CYP2D6 P10635 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CHRNA7 P36544 1/20 0.37
HSD11B1 P28845 2/20 0.36
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
RAD52 P43351 1/20 0.34
GFER P55789 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12018135 1.00 KMT2A (0.40) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
Hydrochloric Acid SCHEMBL15203906 0.97 KMT2A (0.39) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL6247304 0.97 KMT2A (0.39) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL12018055 0.97 ALDH1A1 (0.41) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
Hydrochloric Acid SCHEMBL2597344 0.95 KMT2A (0.38) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
Hydrochloric Acid SCHEMBL6247228 0.95 KMT2A (0.38) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL16568777 0.95 CYP2D6 (0.42) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL4662815 0.91 ALDH1A1 (0.35) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL29998442 0.89 CYP2D6 (0.34) KMT2ACYP2D6ALDH1A1KDM4ECHRNA7
SCHEMBL20061255 0.89 CHKA (0.43) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1928 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2673349-B1 USE OF TRANSITION METAL COMPLEXES AS BLEACH CATALYSTS IN WASHING AND CLEANING COMPOSITIONS WEYLCHEM SWITZERLAND AG (CH) 2015-05-13 EP claimed
US-20140005091-A1 Use of Transition Metal Complexes as Bleach Catalysts in Washing and Cleaning Compositions CLARIANT INTERNATIONAL LTD. (CH) 2014-01-02 US claimed
EP-2673349-A1 USE OF TRANSITION METAL COMPLEXES AS BLEACH CATALYSTS IN WASHING AND CLEANING COMPOSITIONS Clariant International Ltd. (CH) 2013-12-18 EP claimed
EP-1751264-B2 BLEACHING COMPOSITION COMPRISING A CARBOHYDRATE OXIDASE PROCTER & GAMBLE (US) 2013-08-28 EP claimed
WO-2012107187-A1 USE OF TRANSITION METAL COMPLEXES AS BLEACH CATALYSTS IN WASHING AND CLEANING COMPOSITIONS CLARIANT INTERNATIONAL LTD (CH) 2012-08-16 WO claimed
EP-1129164-A1 BLEACH COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-09-05 EP claimed
WO-2000029537-A1 BLEACH COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-05-25 WO claimed
US-20260146243-A1 COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES DANISCO US INC. (US) 2026-05-28 US disclosed
CN-106459939-B Lipase variants and polynucleotides encoding same 诺维信公司 2026-05-22 CN disclosed
WO-2026099337-A1 USE OF GARDENIA BLUE IN LIQUID DETERGENTS, FABRIC SOFTENER AND ALKALINE HARD SURFACE CLEANERS HEUBACH HOLDING SWITZERLAND AG (LTD) (CH) 2026-05-15 WO disclosed
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS NOVOZYMES A/S (DK) 2026-05-14 US disclosed
EP-3434764-B1 FABRIC AND HOME CARE PRODUCTS PROCTER & GAMBLE (US) 2026-04-08 EP disclosed
EP-4717756-A2 LIPASE VARIANTS AND DETERGENT COMPOSITIONS Novozymes A/S (DK) 2026-04-01 EP disclosed
EP-1162257-A1 A process of treating fabrics with a detergent tablet comprising an ion exchange resin THE PROCTER & GAMBLE COMPANY (US) 2001-12-12 EP disclosed
EP-1135392-A2 PROCESS FOR PREPARING CROSS-BRIDGED TETRAAZA MACROCYCLES THE PROCTER & GAMBLE COMPANY (US) 2001-09-26 EP disclosed
EP-1129164-A1 BLEACH COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-09-05 EP disclosed
WO-2001061099-A1 LAUNDRY ADDITIVE SACHET THE PROCTER & GAMBLE COMPANY (US) 2001-08-23 WO disclosed
EP-1126070-A1 Laundry additive sachet THE PROCTER & GAMBLE COMPANY (US) 2001-08-22 EP disclosed
WO-2000032601-A2 PROCESS FOR PREPARING CROSS-BRIDGED TETRAAZA MACROCYCLES THE PROCTER & GAMBLE COMPANY (US) 2000-06-08 WO disclosed
WO-2000029537-A1 BLEACH COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146243-A1 COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES HPN, CTRL, PRSS1 KMT2A 3854/4885CYP2D6 1307/4885ALDH1A1 4512/4885
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS LIPE, LPL, PNLIP KMT2A 2359/4885CYP2D6 703/4885ALDH1A1 3173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.